Atrium Health
Charlotte, North Carolina, 28204, United States
NCT Number: NCT04986943
The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients requiring open abdomen due to necrotizing pancreatitis. The institutions traditional approach is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE has shown in vitro to have improved tension on the abdominal wall that may obviate the need for costly Wittmann patch placement.
Looking for future studies?
Notify Me22 year and older
All sexes
Observational
Charlotte, North Carolina, 28204, United States
The objective of this study is to evaluate the use of the ABTHERA ADVANCE for patients requiring open abdomen due to necrotizing pancreatitis. The instiutions traditional approach is to use the ABTHERA Open Abdomen dressing with Wittmann patch. However, the ABTHERA ADVANCE has shown in vivotro to have improved fascia movement that may obviate the need for costly Wittmann patch placement.
Primary Objective: Determine the variable cost savings associated with use of ABTHERA ADVANCE™ without the use of Wittmann patch Hypothesis: The hypothesis is that with use of the ABTHERA ADVANCE will lead to reduced variable costs compared to ABTHERA Open Abdomen dressing with Wittmann patch Secondary Objective(s): Determine the rate of abdominal closure, component separation, and mesh placement with the ABTHERA ADVANCE™ without the use of Wittmann patch Hypothesis: The hypothesis is that rate of abdominal closure, component separation, and mesh placement will appear similar with use of ABTHERA ADVANCE compared to ABTHERA Open Abdomen dressing with Wittmann patch
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this group, patients will be receiving only the ABTHERA Advance product, without the use of the Wittmann Patch
Time frame: 3 months after the last participant has been enrolled.
Determine the variable cost savings associated with use of ABTHERA ADVANCE™ without the use of Wittmann patch.
Time frame: 3 months after the last participant has been enrolled.
Determine the rate of abdominal closure, component separation, and mesh placement with the ABTHERA ADVANCE™ without the use of Wittmann patch.
Wake Forest University Health Sciences
Other
Use of the ABTHERA ADVANCE™ Open Abdomen Dressing in Patients With Necrotizing Pancreatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06380842
Digestive System Diseases, Infections
Chengdu, China
View Trial DetailsNCT01815489
Digestive System Diseases, Infections
Charlotte, North Carolina, United States
View Trial DetailsNCT03115918
Digestive System Diseases, Necrotizing Pancreatitis
Orlando, Florida, United States
View Trial DetailsNCT03694210
Acute Pancreatic Necrosis, Acute Pancreatitis
Little Rock, Arkansas, United States
View Trial Details